Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinet-ics, Biopharmaceutics, and Biosafety

• Type: Another Publication in an International Scientific Journal
• Date: 2022

Authors

Morsink, M (Author) Other; Parente, L (Author) Other; Silva, F (Author) Other; Abrantes, A (Author) Other; Ramos, A (Author) Other; Primo, I (Author) Other; Willemen, N (Author) Other; Sanchez Lopez, E (Author) Other; Severino, P (Author) Other; Souto, EB (Author) FFUP

Journal

Title: Current Pharmaceutical Design

Vol. 28

Pages: 104-115

ISSN: 1381-6128

Publisher: Bentham

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 1 Citation

Scientific classification

CORDIS: Health sciences

Other information

Authenticus ID: P-00V-XQ9

DOI: 10.2174/1381612827666210804102645

Abstract (EN): With the increasing worldwide rate of chronic diseases, such as cancer, the development of novel techniques to improve the efficacy of therapeutic agents is highly demanded. Nanoparticles are especially well suited to encapsulate drugs and other therapeutic agents, bringing additional advantages, such as less frequent dosage requirements, reduced side effects due to specific targeting, and therefore increased patient compliance. However, with the increasing use of nanoparticles and their recent launch on the pharmaceutical market, it is important to achieve high-quality control of these advanced systems. In this review, we discuss the properties of different nanoparticles, the pharmacokinetics, the biosafety issues of concern, and conclude with novel nanotherapeutics and nanotheragnostics for cancer drug delivery.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 12